Literature DB >> 24305684

Possible association of cutaneous Rosai-Dorfman disease and chronic Crohn disease: a case series report.

Katrin A Salva1, Melissa Stenstrom2, Jonith Y Breadon3, Paul Blair Odland4, Daniel Bennett1, Jack Longley1, Gary S Wood1.   

Abstract

IMPORTANCE Cutaneous Rosai-Dorfman disease (CRDD), a variant of Rosai-Dorfman disease limited to the skin, has a wide range of clinical presentations. Rosai-Dorfman disease is believed to result from an aberrant response to antigens, caused by immunosuppressive macrophages. Macrophage-mediated immunosuppression is also implicated in the pathogenesis of Crohn disease, linking these otherwise unrelated entities. To our knowledge, the coexistence of these disorders has been described in only 2 cases, 1 of them confined to the skin and soft tissue. OBSERVATIONS We present a series of 3 patients who developed purely CRDD in the context of long-standing Crohn disease. Statistical estimates suggested that the association of these 2 disorders is not due to chance (P<.001). CONCLUSIONS AND RELEVANCE Our case series provides the clinical correlate to the pathogenetic parallels between CRDD and Crohn disease. Crohn disease is frequently complicated by various skin manifestations, which may be mimicked by CRDD. Therefore, it may be prudent for clinicians to include CRDD in the list of differential diagnoses when examining skin lesions in patients with Crohn disease.

Entities:  

Mesh:

Year:  2014        PMID: 24305684      PMCID: PMC4058991          DOI: 10.1001/jamadermatol.2013.7609

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN: 2168-6068            Impact factor:   10.282


  15 in total

1.  Successful treatment with azathioprine of relapsing Rosai-Dorfman disease of the central nervous system.

Authors:  Guillaume Le Guenno; Lionel Galicier; Emmanuelle Uro-Coste; Virginie Petitcolin; Virginie Rieu; Marc Ruivard
Journal:  J Neurosurg       Date:  2012-06-22       Impact factor: 5.115

2.  Cutaneous Rosai-Dorfman disease of the forearm: case report.

Authors:  Christopher A Potts; Andrew P Bozeman; Anna N Walker; Waldo E Floyd
Journal:  J Hand Surg Am       Date:  2008-10       Impact factor: 2.230

Review 3.  Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): review of the entity.

Authors:  E Foucar; J Rosai; R Dorfman
Journal:  Semin Diagn Pathol       Date:  1990-02       Impact factor: 3.464

4.  Sinus histiocytosis with massive lymphadenopathy. A newly recognized benign clinicopathological entity.

Authors:  J Rosai; R F Dorfman
Journal:  Arch Pathol       Date:  1969-01

5.  Sinus histiocytosis with massive lymphadenopathy: evidence for its relationship to macrophages and for a cytokine-related disorder.

Authors:  P Middel; B Hemmerlein; A Fayyazi; U Kaboth; H J Radzun
Journal:  Histopathology       Date:  1999-12       Impact factor: 5.087

6.  Expression of macrophage-colony stimulating factor in normal and inflammatory bowel disease intestine.

Authors:  F H Klebl; J E Olsen; S Jain; W F Doe
Journal:  J Pathol       Date:  2001-12       Impact factor: 7.996

7.  Unique CD14 intestinal macrophages contribute to the pathogenesis of Crohn disease via IL-23/IFN-gamma axis.

Authors:  Nobuhiko Kamada; Tadakazu Hisamatsu; Susumu Okamoto; Hiroshi Chinen; Taku Kobayashi; Toshiro Sato; Atsushi Sakuraba; Mina T Kitazume; Akira Sugita; Kazutaka Koganei; Kiyoko S Akagawa; Toshifumi Hibi
Journal:  J Clin Invest       Date:  2008-06       Impact factor: 14.808

8.  Cutaneous rosai-dorfman disease is a distinct clinical entity.

Authors:  Thomas Brenn; Eduardo Calonje; Scott R Granter; Niamh Leonard; Wayne Grayson; Christopher D M Fletcher; Phillip H McKee
Journal:  Am J Dermatopathol       Date:  2002-10       Impact factor: 1.533

9.  Peritoneal macrophages exposed to purified macrophage colony-stimulating factor (M-CSF) suppress mitogen- and antigen-stimulated lymphocyte proliferation.

Authors:  E J Wing; D M Magee; A C Pearson; A Waheed; R K Shadduck
Journal:  J Immunol       Date:  1986-11-01       Impact factor: 5.422

Review 10.  Revisiting Crohn's disease as a primary immunodeficiency of macrophages.

Authors:  Jean-Laurent Casanova; Laurent Abel
Journal:  J Exp Med       Date:  2009-08-17       Impact factor: 14.307

View more
  2 in total

1.  [Cutaneous Rosai-Dorfman syndrome. Successful therapy with intrralesional corticosteroids].

Authors:  S Vandersee; H-J Röwert-Huber; S Wöhner; C Loddenkemper; M Beyer; D Humme
Journal:  Hautarzt       Date:  2014-08       Impact factor: 0.751

2.  A Case of Cutaneous Rosai-Dorfman Disease with underlying calvarial involvement and absence of BRAFV600E mutation.

Authors:  Nadine M Kaskas; Malan Kern; Andrew Johnson; Matthew P Hughes; Matthew Hardee; John Day; Murat Gokden; Sara C Shalin; Ling Gao
Journal:  JAAD Case Rep       Date:  2015-11-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.